Biblio
sdf1 expression reveals a source of perivascular-derived mesenchymal stem cells in zebrafish. Stem Cells. 2014.
. Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD). Transplantation. 2016.
Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children With Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2015.
Placenta-based therapies for the treatment of epidermolysis bullosa. Cytotherapy. 2015.
. Peripheral Neuro-Immune Pathology in Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2014.
. P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss. PLoS One. 2022;17(1):e0261770.
A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome. Exp Eye Res. 2016.
. miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2016.
. A living band-aid for epidermolysis bullosa. Blood Transfus. 2015;13(1):1-2.
. Integrating Porous Silicon Nanoneedles within Medical Devices for Nucleic Acid Nanoinjection. ACS Nano. 2024.
Future Applications of 3D Bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa. Exp Dermatol. 2021.
. . . Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782-788/1562]. Cytotherapy. 2023;25(9):1016.
A Biologic Velcro Patch. N Engl J Med. 2015;372(4):382-384.
. Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs. J Invest Dermatol. 2019.
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology. J Inherit Metab Dis. 2016.
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood. 2024.
Advances in understanding and treating dystrophic epidermolysis bullosa. F1000Prime Rep. 2014;6:35.
. Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2024.
ABCB5 mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy. 2023.
A 3D in vitro model of the dermoepidermal junction amenable to mechanical testing. J Biomed Mater Res A. 2018.
.